Neubauer, Horst <br/><br/>
How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 2008 
 - 357-62 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Standard No.: </label>10.1160/TH07-10-0624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--analogs & derivatives<br/>Aged<br/>Algorithms<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Aspirin--administration & dosage<br/>Blood Platelets--drug effects<br/>Cardiovascular Diseases--blood<br/>Clinical Protocols<br/>Clopidogrel<br/>Coronary Artery Disease--blood<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Monitoring--methods<br/>Drug Resistance<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Function Tests<br/>Prospective Studies<br/>Purinergic P2 Receptor Antagonists<br/>Receptors, Purinergic P2--blood<br/>Receptors, Purinergic P2Y12<br/>Stents<br/>Ticlopidine--administration & dosage